Global Targeted Small Molecule Drug Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI03257412

Publication Date:

March 4, 2025

Pages:

126

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Targeted Small Molecule Drug market size is predicted to grow from US$ 65370 million in 2025 to US$ 113610 million in 2031; it is expected to grow at a CAGR of 9.6% from 2025 to 2031.
Targeted therapy is听a type of cancer treatment that uses drugs or other substances to precisely identify and attack certain types of cancer cells. A targeted therapy can be used by itself or in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淭argeted Small Molecule Drug Industry Forecast鈥� looks at past sales and reviews total world Targeted Small Molecule Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Targeted Small Molecule Drug sales for 2025 through 2031. With Targeted Small Molecule Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Small Molecule Drug industry.
This Insight Report provides a comprehensive analysis of the global Targeted Small Molecule Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Small Molecule Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Targeted Small Molecule Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Small Molecule Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Small Molecule Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Small Molecule Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
Sorafenib
Lenvatinib
Regorafenib
Osimertinib
Anlotinib
Alectinib
Other
Segmentation by Application:
Hospital
Retail Pharmacy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bayer
Eisai
Zelgen
Cipla
Natco Pharma
AstraZeneca
Novartis
Roche
Bristol-Myers Squibb
Pfizer
BEACON Pharma
Jiangxi Shanxiang
Yao Pharma
CSPC
CHIATAI Tianqing
Simcere

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Targeted Small Molecule Drug Market Size (2020-2031)
2.1.2 Targeted Small Molecule Drug Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Targeted Small Molecule Drug by Country/Region (2020, 2024 & 2031)
2.2 Targeted Small Molecule Drug Segment by Type
2.2.1 Sorafenib
2.2.2 Lenvatinib
2.2.3 Regorafenib
2.2.4 Osimertinib
2.2.5 Anlotinib
2.2.6 Alectinib
2.2.7 Other
2.3 Targeted Small Molecule Drug Market Size by Type
2.3.1 Targeted Small Molecule Drug Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Targeted Small Molecule Drug Market Size Market Share by Type (2020-2025)
2.4 Targeted Small Molecule Drug Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Other
2.5 Targeted Small Molecule Drug Market Size by Application
2.5.1 Targeted Small Molecule Drug Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Targeted Small Molecule Drug Market Size Market Share by Application (2020-2025)
3 Targeted Small Molecule Drug Market Size by Player
3.1 Targeted Small Molecule Drug Market Size Market Share by Player
3.1.1 Global Targeted Small Molecule Drug Revenue by Player (2020-2025)
3.1.2 Global Targeted Small Molecule Drug Revenue Market Share by Player (2020-2025)
3.2 Global Targeted Small Molecule Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Targeted Small Molecule Drug by Region
4.1 Targeted Small Molecule Drug Market Size by Region (2020-2025)
4.2 Global Targeted Small Molecule Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Targeted Small Molecule Drug Market Size Growth (2020-2025)
4.4 APAC Targeted Small Molecule Drug Market Size Growth (2020-2025)
4.5 Europe Targeted Small Molecule Drug Market Size Growth (2020-2025)
4.6 Middle East & Africa Targeted Small Molecule Drug Market Size Growth (2020-2025)
5 Americas
5.1 Americas Targeted Small Molecule Drug Market Size by Country (2020-2025)
5.2 Americas Targeted Small Molecule Drug Market Size by Type (2020-2025)
5.3 Americas Targeted Small Molecule Drug Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Small Molecule Drug Market Size by Region (2020-2025)
6.2 APAC Targeted Small Molecule Drug Market Size by Type (2020-2025)
6.3 APAC Targeted Small Molecule Drug Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Targeted Small Molecule Drug Market Size by Country (2020-2025)
7.2 Europe Targeted Small Molecule Drug Market Size by Type (2020-2025)
7.3 Europe Targeted Small Molecule Drug Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Targeted Small Molecule Drug by Region (2020-2025)
8.2 Middle East & Africa Targeted Small Molecule Drug Market Size by Type (2020-2025)
8.3 Middle East & Africa Targeted Small Molecule Drug Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Targeted Small Molecule Drug Market Forecast
10.1 Global Targeted Small Molecule Drug Forecast by Region (2026-2031)
10.1.1 Global Targeted Small Molecule Drug Forecast by Region (2026-2031)
10.1.2 Americas Targeted Small Molecule Drug Forecast
10.1.3 APAC Targeted Small Molecule Drug Forecast
10.1.4 Europe Targeted Small Molecule Drug Forecast
10.1.5 Middle East & Africa Targeted Small Molecule Drug Forecast
10.2 Americas Targeted Small Molecule Drug Forecast by Country (2026-2031)
10.2.1 United States Market Targeted Small Molecule Drug Forecast
10.2.2 Canada Market Targeted Small Molecule Drug Forecast
10.2.3 Mexico Market Targeted Small Molecule Drug Forecast
10.2.4 Brazil Market Targeted Small Molecule Drug Forecast
10.3 APAC Targeted Small Molecule Drug Forecast by Region (2026-2031)
10.3.1 China Targeted Small Molecule Drug Market Forecast
10.3.2 Japan Market Targeted Small Molecule Drug Forecast
10.3.3 Korea Market Targeted Small Molecule Drug Forecast
10.3.4 Southeast Asia Market Targeted Small Molecule Drug Forecast
10.3.5 India Market Targeted Small Molecule Drug Forecast
10.3.6 Australia Market Targeted Small Molecule Drug Forecast
10.4 Europe Targeted Small Molecule Drug Forecast by Country (2026-2031)
10.4.1 Germany Market Targeted Small Molecule Drug Forecast
10.4.2 France Market Targeted Small Molecule Drug Forecast
10.4.3 UK Market Targeted Small Molecule Drug Forecast
10.4.4 Italy Market Targeted Small Molecule Drug Forecast
10.4.5 Russia Market Targeted Small Molecule Drug Forecast
10.5 Middle East & Africa Targeted Small Molecule Drug Forecast by Region (2026-2031)
10.5.1 Egypt Market Targeted Small Molecule Drug Forecast
10.5.2 South Africa Market Targeted Small Molecule Drug Forecast
10.5.3 Israel Market Targeted Small Molecule Drug Forecast
10.5.4 Turkey Market Targeted Small Molecule Drug Forecast
10.6 Global Targeted Small Molecule Drug Forecast by Type (2026-2031)
10.7 Global Targeted Small Molecule Drug Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Targeted Small Molecule Drug Forecast
11 Key Players Analysis
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Targeted Small Molecule Drug Product Offered
11.1.3 Bayer Targeted Small Molecule Drug Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Eisai
11.2.1 Eisai Company Information
11.2.2 Eisai Targeted Small Molecule Drug Product Offered
11.2.3 Eisai Targeted Small Molecule Drug Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Eisai Main Business Overview
11.2.5 Eisai Latest Developments
11.3 Zelgen
11.3.1 Zelgen Company Information
11.3.2 Zelgen Targeted Small Molecule Drug Product Offered
11.3.3 Zelgen Targeted Small Molecule Drug Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Zelgen Main Business Overview
11.3.5 Zelgen Latest Developments
11.4 Cipla
11.4.1 Cipla Company Information
11.4.2 Cipla Targeted Small Molecule Drug Product Offered
11.4.3 Cipla Targeted Small Molecule Drug Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Cipla Main Business Overview
11.4.5 Cipla Latest Developments
11.5 Natco Pharma
11.5.1 Natco Pharma Company Information
11.5.2 Natco Pharma Targeted Small Molecule Drug Product Offered
11.5.3 Natco Pharma Targeted Small Molecule Drug Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Natco Pharma Main Business Overview
11.5.5 Natco Pharma Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Targeted Small Molecule Drug Product Offered
11.6.3 AstraZeneca Targeted Small Molecule Drug Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Targeted Small Molecule Drug Product Offered
11.7.3 Novartis Targeted Small Molecule Drug Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 Roche
11.8.1 Roche Company Information
11.8.2 Roche Targeted Small Molecule Drug Product Offered
11.8.3 Roche Targeted Small Molecule Drug Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Roche Main Business Overview
11.8.5 Roche Latest Developments
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Information
11.9.2 Bristol-Myers Squibb Targeted Small Molecule Drug Product Offered
11.9.3 Bristol-Myers Squibb Targeted Small Molecule Drug Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Bristol-Myers Squibb Main Business Overview
11.9.5 Bristol-Myers Squibb Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Targeted Small Molecule Drug Product Offered
11.10.3 Pfizer Targeted Small Molecule Drug Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 BEACON Pharma
11.11.1 BEACON Pharma Company Information
11.11.2 BEACON Pharma Targeted Small Molecule Drug Product Offered
11.11.3 BEACON Pharma Targeted Small Molecule Drug Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 BEACON Pharma Main Business Overview
11.11.5 BEACON Pharma Latest Developments
11.12 Jiangxi Shanxiang
11.12.1 Jiangxi Shanxiang Company Information
11.12.2 Jiangxi Shanxiang Targeted Small Molecule Drug Product Offered
11.12.3 Jiangxi Shanxiang Targeted Small Molecule Drug Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Jiangxi Shanxiang Main Business Overview
11.12.5 Jiangxi Shanxiang Latest Developments
11.13 Yao Pharma
11.13.1 Yao Pharma Company Information
11.13.2 Yao Pharma Targeted Small Molecule Drug Product Offered
11.13.3 Yao Pharma Targeted Small Molecule Drug Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Yao Pharma Main Business Overview
11.13.5 Yao Pharma Latest Developments
11.14 CSPC
11.14.1 CSPC Company Information
11.14.2 CSPC Targeted Small Molecule Drug Product Offered
11.14.3 CSPC Targeted Small Molecule Drug Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 CSPC Main Business Overview
11.14.5 CSPC Latest Developments
11.15 CHIATAI Tianqing
11.15.1 CHIATAI Tianqing Company Information
11.15.2 CHIATAI Tianqing Targeted Small Molecule Drug Product Offered
11.15.3 CHIATAI Tianqing Targeted Small Molecule Drug Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 CHIATAI Tianqing Main Business Overview
11.15.5 CHIATAI Tianqing Latest Developments
11.16 Simcere
11.16.1 Simcere Company Information
11.16.2 Simcere Targeted Small Molecule Drug Product Offered
11.16.3 Simcere Targeted Small Molecule Drug Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Simcere Main Business Overview
11.16.5 Simcere Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂